Global Health Limited (NSE:MEDANTA)

Global Health Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Operating Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Income	5,565	4,814	4,782	3,261	1,962
Depreciation & Amortization	2,225	1,919	1,702	1,474	1,275
Other Amortization	-	18.35	25.02	25.04	22.57
Loss (Gain) From Sale of Assets	-0.79	-2.19	-8.2	6.77	-2.94
Asset Writedown & Restructuring Costs	-	-	-	-	17.38
Loss (Gain) From Sale of Investments	-	192.25	293.13	76.19	-
Stock-Based Compensation	382.98	-	1.56	7.48	91.66
Provision & Write-off of Bad Debts	107.85	-	-	-	33.36
Other Operating Activities	-283.93	292.73	-215.76	566.62	381.72
Change in Accounts Receivable	-1,303	-949.07	-484.06	-214.56	-495.64
Change in Inventory	-118.42	-2.91	-64.79	-69.83	-136.29
Change in Accounts Payable	535.68	125.88	17.69	603.62	27.78
Change in Other Net Operating Assets	33.32	-170.95	72.05	708.96	-63.52
Operating Cash Flow	7,144	6,238	6,121	6,445	3,113
Operating Cash Flow Growth	14.53%	1.91%	-5.03%	107.07%	28.74%

Investing Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Capital Expenditures	-8,382	-5,165	-2,786	-2,360	-2,745
Sale of Property, Plant & Equipment	8.47	29.94	14.27	7.97	13.84
Sale (Purchase) of Real Estate	-1,404	-	-	-	-
Investment in Securities	-1,889	-1,432	-2,226	-1,416	-1,642
Other Investing Activities	775.64	-641.96	589.2	344.54	163.83
Investing Cash Flow	-10,891	-7,209	-4,408	-3,423	-4,209

Financing Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Long-Term Debt Issued	3,687	1,492	1,363	390.75	2,351
Long-Term Debt Repaid	-251.6	-1,940	-5,935	-796.46	-367.4
Total Debt Repaid	-251.6	-1,940	-5,935	-796.46	-367.4
Net Debt Issued (Repaid)	3,435	-448.12	-4,572	-405.71	1,984
Issuance of Common Stock	0.21	0.16	0.07	4,785	379.52
Repurchase of Common Stock	-98.24	-	-	-	-
Common Dividends Paid	-134.4	-	-	-	-
Other Financing Activities	-484.08	-524.3	-567.12	-923.4	-767.27
Financing Cash Flow	2,719	-972.26	-5,139	3,456	1,596

Net Cash Flow

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Cash Flow	-1,029	-1,944	-3,426	6,478	499.66

Free Cash Flow

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Free Cash Flow	-1,238	1,072	3,335	4,085	367.87
Free Cash Flow Growth	-	-67.85%	-18.37%	1010.54%	-61.69%
Free Cash Flow Margin	-2.81%	2.90%	10.18%	15.08%	1.69%
Free Cash Flow Per Share	-4.60	3.99	12.42	15.74	1.46
Levered Free Cash Flow	-2,142	129.77	2,208	2,931	-418.52
Unlevered Free Cash Flow	-1,647	529.92	2,661	3,415	74.96

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash Interest Paid	724.08	536.8	567.12	888.11	761.97
Cash Income Tax Paid	1,194	1,642	1,775	1,061	980.19
Change in Working Capital	-852.2	-997.05	-459.11	1,028	-667.67

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 21, 2026

Data Sources Report a data error